Weekly Newsletters


Sign up for our weekly newsletter! Receive articles of interest with a wide variety of subjects associated with psychiatry and the practice of primary care medicine. Just add your email address below or email pc2@vistahill.org.


    Motivational Interviewing 8/17/2017

    Motivational interviewing (MI) is a technique that can be applicable to all clinical settings including primary care. MI is defined as “a person-centered, goal-oriented approach for facilitating change by exploring and resolving ambivalence” (Miller 2006). It can be useful in situations when a patient’s behavioral choices negatively impact his/her health condition – examples include smoking, […]

    Cannabis-Induced Psychosis 8/24/2017

    As cannabis use increases, with easier access and recent legislation, there has been significant emerging evidence for cannabis-related risks. It is important for primary care providers to be aware of these, because a primary care office may be the place where patients present with these negative effects and educating patients about the potential risks is […]

    CBT for Insomnia 8/31/2017

    Insomnia is one of the primary presenting complaints in the primary care setting. It can be the only symptom the patient is reporting or it can be part of a constellation of symptoms related to a medical cause or mood or anxiety disorder. That, of course, has to be investigated first. Once that has been […]

    Interactions: BCP’s and Psychotropic Meds 9/7/2017

    Contraceptives are commonly used in women of childbearing age, many of who are also taking psychotropic medications for mental health concerns. It is important to be aware of the interactions between contraceptives and certain psychotropic medications as well as the psychiatric side effects of contraceptives themselves. Contraceptives have synthetic estrogen, progesterone or a combination of […]

    Pharmacogenetic Testing in Psychiatry 9/14/2017

    There has been increasing interest in the use of pharmacogenomic testing to help with medication choice when treating psychiatric conditions. Advocates are claiming they can be helpful for personalizing prescribing, improving outcomes, and reducing costs. Some of these commercial tests are now covered by some insurance companies. While clinicians would love to have a way […]

    Premenstrual Dysphoric Disorder (PMDD) 9/21/2017

    Approximately 75% of women experience premenstrual changes – increased irritability, tension, depressed mood, breast tenderness and bloating – commonly referred to as premenstrual syndrome (PMS). About 5-10% of women experience moderate to severe premenstrual mood symptoms known as premenstrual dysphoric disorder (PMDD). PMDD includes depressed mood, irritability, mood lability, anxiety, anger, difficulty concentrating, and insomnia […]

    Important Drug Interactions with SSRI’s 9/28/2017

    Selective serotonin reuptake inhibitors (SSRIs) are commonly used psychotropic medications to treat depression and anxiety. It is important to be aware of common drug interactions between them and other medications, especially because some SSRIs are competitive inhibitors of a variety of cytochrome P450 liver enzymes. Therefore, they can dramatically increase the blood levels of medications […]

    Complementary and/or Alternative Medicine Concerns 10/5/2017

    Many people are interested in using complementary and/or alternative medicine (CAM) when they are dealing with physical or mental health concerns. This is sometimes because they are worried about side effects from traditional medical treatments. Sometimes it is because they are not seeing the relief they expected from the traditional treatment prescribed by their medical […]

    Supported vs. Unsupported Off Label Prescribing 10/12/2017

    Off-label prescribing is a central and common source of treatment throughout medicine, particularly psychiatry. Lack of FDA indication does not equate to lack of evidence. It is therefore important to distinguish between supported and unsupported off-label prescribing practices. Supported off-label prescribing is the use of medications for a non-FDA-approved indication with clinical literature to support […]